Review



dnase treatment  (Qiagen)


Bioz Verified Symbol Qiagen is a verified supplier
Bioz Manufacturer Symbol Qiagen manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    Qiagen dnase treatment
    Dnase Treatment, supplied by Qiagen, used in various techniques. Bioz Stars score: 99/100, based on 26966 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dnase/RNase-Free+DNase+Set/pmc13051718-357-1-3
    Average 99 stars, based on 26966 article reviews
    dnase treatment - by Bioz Stars, 2026-11
    99/100 stars

    Images

    Related Articles

    Isolation:

    Article Title: Fentanyl and fentanyl-xylazine co-exposure influence mitochondrial transcriptional programs in human trophoblasts
    Article Snippet: .. Total RNAs were extracted on day 4 or day 9, using TRIzol RNA isolation reagent (Thermo Fisher, #15596026), followed by purification with the RNeasy mini kit (Qiagen, #74104) including on-column RNase-free DNase (Qiagen, #79254), according to the manufacturer’s protocols as previously described . .. RNA quality was assessed using an Agilent HS Total RNA 15-nt kit (Agilent, DNF-472T33) on an Agilent Analytical 5300 Fragment Analyzer.

    Purification:

    Article Title: Fentanyl and fentanyl-xylazine co-exposure influence mitochondrial transcriptional programs in human trophoblasts
    Article Snippet: .. Total RNAs were extracted on day 4 or day 9, using TRIzol RNA isolation reagent (Thermo Fisher, #15596026), followed by purification with the RNeasy mini kit (Qiagen, #74104) including on-column RNase-free DNase (Qiagen, #79254), according to the manufacturer’s protocols as previously described . .. RNA quality was assessed using an Agilent HS Total RNA 15-nt kit (Agilent, DNF-472T33) on an Agilent Analytical 5300 Fragment Analyzer.

    Article Title: Serum Response Factor Cooperates With Progesterone Receptor to Regulate Oviductal Smooth Muscle Gene Expression During Preimplantation Embryo Transport
    Article Snippet: The mixture was then passed through the Rneasy Mini Kit RNA binding column (Qiagen, Germantown, MD, USA; catalog no. 74104), followed by washing and elution steps described in the manufacturer's handbook. .. Samples destined for RNA‐seq analysis were purified from genomic DNA contamination by treatment with the Rnase‐Free DNase Set (Qiagen, Germantown, MD, USA; catalog no. 79254) according to the manufacturer's instructions. .. RNA concentration was quantified using the Invitrogen Qubit RNA BR Assay Kit (Thermo Fisher Scientific, Waltham, MA, USA; catalog no. Q10210 ) and the RNA integrity ascertained using Agilent RNA ScreenTape (Agilent, Santa Clara, CA, USA; part no. 5067‐5576).

    RNA Sequencing:

    Article Title: Serum Response Factor Cooperates With Progesterone Receptor to Regulate Oviductal Smooth Muscle Gene Expression During Preimplantation Embryo Transport
    Article Snippet: The mixture was then passed through the Rneasy Mini Kit RNA binding column (Qiagen, Germantown, MD, USA; catalog no. 74104), followed by washing and elution steps described in the manufacturer's handbook. .. Samples destined for RNA‐seq analysis were purified from genomic DNA contamination by treatment with the Rnase‐Free DNase Set (Qiagen, Germantown, MD, USA; catalog no. 79254) according to the manufacturer's instructions. .. RNA concentration was quantified using the Invitrogen Qubit RNA BR Assay Kit (Thermo Fisher Scientific, Waltham, MA, USA; catalog no. Q10210 ) and the RNA integrity ascertained using Agilent RNA ScreenTape (Agilent, Santa Clara, CA, USA; part no. 5067‐5576).

    Analysis:

    Article Title: Serum Response Factor Cooperates With Progesterone Receptor to Regulate Oviductal Smooth Muscle Gene Expression During Preimplantation Embryo Transport
    Article Snippet: The mixture was then passed through the Rneasy Mini Kit RNA binding column (Qiagen, Germantown, MD, USA; catalog no. 74104), followed by washing and elution steps described in the manufacturer's handbook. .. Samples destined for RNA‐seq analysis were purified from genomic DNA contamination by treatment with the Rnase‐Free DNase Set (Qiagen, Germantown, MD, USA; catalog no. 79254) according to the manufacturer's instructions. .. RNA concentration was quantified using the Invitrogen Qubit RNA BR Assay Kit (Thermo Fisher Scientific, Waltham, MA, USA; catalog no. Q10210 ) and the RNA integrity ascertained using Agilent RNA ScreenTape (Agilent, Santa Clara, CA, USA; part no. 5067‐5576).

    Tissue:

    Article Title: Alternative splicing of a species- and skeletal muscle-specific microexon diversifies the menu of clathrin heavy chains in mice and rats.
    Article Snippet: Tissues were homogenized as described above in RLT buffer supplemented with 0.143 M 2-mercaptoethanol (Sigma-Aldrich, M6250). .. RNA was extracted using the RNeasy Fibrous Tissue Mini kit (Qiagen, #74704) and treated with DNase I (Qiagen, #79254) following the manufacturer’s recommended protocol. ..



    Similar Products

    99
    New England Biolabs dnase i
    Enhanced performance of Hypernova sensors. ( A ) RNase sensor. ( B ) Initial rates of light production of sensors that use either Hypernova (rHN) or Supernova (rSN) as a signaling domain. Sensors were tested after preincubation in either the absence or presence of RNase A. ( C ) DNase sensor. ( D ) Initial rates of light production of sensors that use either Hypernova (HN) or Supernova (SN) as a signaling domain. Sensors were tested after preincubation in either the absence or presence of DNase I. ( E ) APOBEC3A sensor. ( F ) Initial rates of light production of sensors that use either Hypernova (HN) or Supernova (aSN) as a signaling domain. Sensors were tested after preincubation in either the absence or presence of APOBEC3A. In all cases, N = 3, and error bars represent one standard deviation.
    Dnase I, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dnase/DNase+I/pmc13760218-107-14-16
    Average 99 stars, based on 1 article reviews
    dnase i - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    95
    Zymo Research dnase i
    Enhanced performance of Hypernova sensors. ( A ) RNase sensor. ( B ) Initial rates of light production of sensors that use either Hypernova (rHN) or Supernova (rSN) as a signaling domain. Sensors were tested after preincubation in either the absence or presence of RNase A. ( C ) DNase sensor. ( D ) Initial rates of light production of sensors that use either Hypernova (HN) or Supernova (SN) as a signaling domain. Sensors were tested after preincubation in either the absence or presence of DNase I. ( E ) APOBEC3A sensor. ( F ) Initial rates of light production of sensors that use either Hypernova (HN) or Supernova (aSN) as a signaling domain. Sensors were tested after preincubation in either the absence or presence of APOBEC3A. In all cases, N = 3, and error bars represent one standard deviation.
    Dnase I, supplied by Zymo Research, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dnase/DNase+I+Set+w%2F+DNA+Digestion+Buffer/pmc13759040-139-4-7
    Average 95 stars, based on 1 article reviews
    dnase i - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    99
    Thermo Fisher rnase
    Enhanced performance of Hypernova sensors. ( A ) RNase sensor. ( B ) Initial rates of light production of sensors that use either Hypernova (rHN) or Supernova (rSN) as a signaling domain. Sensors were tested after preincubation in either the absence or presence of RNase A. ( C ) DNase sensor. ( D ) Initial rates of light production of sensors that use either Hypernova (HN) or Supernova (SN) as a signaling domain. Sensors were tested after preincubation in either the absence or presence of DNase I. ( E ) APOBEC3A sensor. ( F ) Initial rates of light production of sensors that use either Hypernova (HN) or Supernova (aSN) as a signaling domain. Sensors were tested after preincubation in either the absence or presence of APOBEC3A. In all cases, N = 3, and error bars represent one standard deviation.
    Rnase, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dnase/Water%2C+RNase%2C+DNase-free/pmc13234486-106-8-13
    Average 99 stars, based on 1 article reviews
    rnase - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    96
    New England Biolabs dnase i reaction buffer
    Enhanced performance of Hypernova sensors. ( A ) RNase sensor. ( B ) Initial rates of light production of sensors that use either Hypernova (rHN) or Supernova (rSN) as a signaling domain. Sensors were tested after preincubation in either the absence or presence of RNase A. ( C ) DNase sensor. ( D ) Initial rates of light production of sensors that use either Hypernova (HN) or Supernova (SN) as a signaling domain. Sensors were tested after preincubation in either the absence or presence of DNase I. ( E ) APOBEC3A sensor. ( F ) Initial rates of light production of sensors that use either Hypernova (HN) or Supernova (aSN) as a signaling domain. Sensors were tested after preincubation in either the absence or presence of APOBEC3A. In all cases, N = 3, and error bars represent one standard deviation.
    Dnase I Reaction Buffer, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dnase/DNase+I+Reaction+Buffer/pmc13760218-107-6-16
    Average 96 stars, based on 1 article reviews
    dnase i reaction buffer - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    93
    MedChemExpress dnase i
    DNA-binding-dependent association between TCF3 and CXXC1 in promoting target gene transcription. ( A ) RNA-seq-derived expression changes in Pabpn1l in Tcf3 oo−/− and Cxxc1 oo−/− GV oocytes relative to their respective WT controls. Data are shown as log 2 fold changes. ( B ) Dual-luciferase reporter analysis of Pabpn1l promoter activity following expression of TCF3, CXXC1, or both proteins. The Btg4 promoter was used as a non-target control, and TCF12 was included as a paralog control. ( C ) Co-IP analysis of the association between ectopically expressed FLAG-TCF3 and HA-CXXC1 in HeLa cells with or without <t>DNase</t> <t>I</t> treatment. ( D ) Co-IP analysis of WT and DNA-binding-deficient TCF3 and CXXC1 proteins in GV oocytes following mRNA microinjection. The TCF3 E553A, R556A mutant is defective in sequence-specific DNA binding, whereas the CXXC1 C173A mutant is defective in CpG recognition. ( E ) Representative immunofluorescence images showing the localization of WT mCherry-TCF3 or the mCherry-TCF3 E553A, R556A mutant relative to H3K4me3 in GV oocytes following mRNA microinjection. Images showing the GV region only. Scale bar, 10 μm. Data in ( B ) are presented as mean ± SD. Adjusted P values in ( A ) were obtained from DESeq2 using the Wald test with Benjamini–Hochberg correction. Statistical significance in ( B ) was determined using one-way analysis of variance (ANOVA) followed by Tukey’s HSD post hoc test for multiple comparisons. n.s. not significant; * P < 0.05; ** P < 0.01; *** P < 0.001.
    Dnase I, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dnase/DNase+I%2C+Human/pmc13748978-116-5-10
    Average 93 stars, based on 1 article reviews
    dnase i - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    98
    New England Biolabs dnase i xt
    DNA-binding-dependent association between TCF3 and CXXC1 in promoting target gene transcription. ( A ) RNA-seq-derived expression changes in Pabpn1l in Tcf3 oo−/− and Cxxc1 oo−/− GV oocytes relative to their respective WT controls. Data are shown as log 2 fold changes. ( B ) Dual-luciferase reporter analysis of Pabpn1l promoter activity following expression of TCF3, CXXC1, or both proteins. The Btg4 promoter was used as a non-target control, and TCF12 was included as a paralog control. ( C ) Co-IP analysis of the association between ectopically expressed FLAG-TCF3 and HA-CXXC1 in HeLa cells with or without <t>DNase</t> <t>I</t> treatment. ( D ) Co-IP analysis of WT and DNA-binding-deficient TCF3 and CXXC1 proteins in GV oocytes following mRNA microinjection. The TCF3 E553A, R556A mutant is defective in sequence-specific DNA binding, whereas the CXXC1 C173A mutant is defective in CpG recognition. ( E ) Representative immunofluorescence images showing the localization of WT mCherry-TCF3 or the mCherry-TCF3 E553A, R556A mutant relative to H3K4me3 in GV oocytes following mRNA microinjection. Images showing the GV region only. Scale bar, 10 μm. Data in ( B ) are presented as mean ± SD. Adjusted P values in ( A ) were obtained from DESeq2 using the Wald test with Benjamini–Hochberg correction. Statistical significance in ( B ) was determined using one-way analysis of variance (ANOVA) followed by Tukey’s HSD post hoc test for multiple comparisons. n.s. not significant; * P < 0.05; ** P < 0.01; *** P < 0.001.
    Dnase I Xt, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dnase/DNase+I-XT/bio_rxiv__64898__2026__11__06__764861-328-4-7
    Average 98 stars, based on 1 article reviews
    dnase i xt - by Bioz Stars, 2026-11
    98/100 stars
      Buy from Supplier

    99
    Worthington Biochemical dnase i
    DNA-binding-dependent association between TCF3 and CXXC1 in promoting target gene transcription. ( A ) RNA-seq-derived expression changes in Pabpn1l in Tcf3 oo−/− and Cxxc1 oo−/− GV oocytes relative to their respective WT controls. Data are shown as log 2 fold changes. ( B ) Dual-luciferase reporter analysis of Pabpn1l promoter activity following expression of TCF3, CXXC1, or both proteins. The Btg4 promoter was used as a non-target control, and TCF12 was included as a paralog control. ( C ) Co-IP analysis of the association between ectopically expressed FLAG-TCF3 and HA-CXXC1 in HeLa cells with or without <t>DNase</t> <t>I</t> treatment. ( D ) Co-IP analysis of WT and DNA-binding-deficient TCF3 and CXXC1 proteins in GV oocytes following mRNA microinjection. The TCF3 E553A, R556A mutant is defective in sequence-specific DNA binding, whereas the CXXC1 C173A mutant is defective in CpG recognition. ( E ) Representative immunofluorescence images showing the localization of WT mCherry-TCF3 or the mCherry-TCF3 E553A, R556A mutant relative to H3K4me3 in GV oocytes following mRNA microinjection. Images showing the GV region only. Scale bar, 10 μm. Data in ( B ) are presented as mean ± SD. Adjusted P values in ( A ) were obtained from DESeq2 using the Wald test with Benjamini–Hochberg correction. Statistical significance in ( B ) was determined using one-way analysis of variance (ANOVA) followed by Tukey’s HSD post hoc test for multiple comparisons. n.s. not significant; * P < 0.05; ** P < 0.01; *** P < 0.001.
    Dnase I, supplied by Worthington Biochemical, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dnase/Deoxyribonuclease+I/bio_rxiv__64898__2026__11__04__764362-103-37-40
    Average 99 stars, based on 1 article reviews
    dnase i - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    95
    tiangen biotech co depc water
    DNA-binding-dependent association between TCF3 and CXXC1 in promoting target gene transcription. ( A ) RNA-seq-derived expression changes in Pabpn1l in Tcf3 oo−/− and Cxxc1 oo−/− GV oocytes relative to their respective WT controls. Data are shown as log 2 fold changes. ( B ) Dual-luciferase reporter analysis of Pabpn1l promoter activity following expression of TCF3, CXXC1, or both proteins. The Btg4 promoter was used as a non-target control, and TCF12 was included as a paralog control. ( C ) Co-IP analysis of the association between ectopically expressed FLAG-TCF3 and HA-CXXC1 in HeLa cells with or without <t>DNase</t> <t>I</t> treatment. ( D ) Co-IP analysis of WT and DNA-binding-deficient TCF3 and CXXC1 proteins in GV oocytes following mRNA microinjection. The TCF3 E553A, R556A mutant is defective in sequence-specific DNA binding, whereas the CXXC1 C173A mutant is defective in CpG recognition. ( E ) Representative immunofluorescence images showing the localization of WT mCherry-TCF3 or the mCherry-TCF3 E553A, R556A mutant relative to H3K4me3 in GV oocytes following mRNA microinjection. Images showing the GV region only. Scale bar, 10 μm. Data in ( B ) are presented as mean ± SD. Adjusted P values in ( A ) were obtained from DESeq2 using the Wald test with Benjamini–Hochberg correction. Statistical significance in ( B ) was determined using one-way analysis of variance (ANOVA) followed by Tukey’s HSD post hoc test for multiple comparisons. n.s. not significant; * P < 0.05; ** P < 0.01; *** P < 0.001.
    Depc Water, supplied by tiangen biotech co, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dnase/DNase%2FRNase-Free+Deionized+Water/pmc13761438-107-72-77
    Average 95 stars, based on 1 article reviews
    depc water - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    Image Search Results


    Enhanced performance of Hypernova sensors. ( A ) RNase sensor. ( B ) Initial rates of light production of sensors that use either Hypernova (rHN) or Supernova (rSN) as a signaling domain. Sensors were tested after preincubation in either the absence or presence of RNase A. ( C ) DNase sensor. ( D ) Initial rates of light production of sensors that use either Hypernova (HN) or Supernova (SN) as a signaling domain. Sensors were tested after preincubation in either the absence or presence of DNase I. ( E ) APOBEC3A sensor. ( F ) Initial rates of light production of sensors that use either Hypernova (HN) or Supernova (aSN) as a signaling domain. Sensors were tested after preincubation in either the absence or presence of APOBEC3A. In all cases, N = 3, and error bars represent one standard deviation.

    Journal: Nucleic Acids Research

    Article Title: Hypernova: a faster and brighter light-producing deoxyribozyme

    doi: 10.1093/nar/gkag1143

    Figure Lengend Snippet: Enhanced performance of Hypernova sensors. ( A ) RNase sensor. ( B ) Initial rates of light production of sensors that use either Hypernova (rHN) or Supernova (rSN) as a signaling domain. Sensors were tested after preincubation in either the absence or presence of RNase A. ( C ) DNase sensor. ( D ) Initial rates of light production of sensors that use either Hypernova (HN) or Supernova (SN) as a signaling domain. Sensors were tested after preincubation in either the absence or presence of DNase I. ( E ) APOBEC3A sensor. ( F ) Initial rates of light production of sensors that use either Hypernova (HN) or Supernova (aSN) as a signaling domain. Sensors were tested after preincubation in either the absence or presence of APOBEC3A. In all cases, N = 3, and error bars represent one standard deviation.

    Article Snippet: HPLC-purified oligonucleotides were incubated with 1× DNase I Reaction Buffer and 2 U of DNase I (NEB) in a total volume of 20 μl at 37°C for 30 min. Next, water and 5× selection buffer were added and samples were transferred to a white half-area 96-well plate (Corning).

    Techniques: Standard Deviation

    DNA-binding-dependent association between TCF3 and CXXC1 in promoting target gene transcription. ( A ) RNA-seq-derived expression changes in Pabpn1l in Tcf3 oo−/− and Cxxc1 oo−/− GV oocytes relative to their respective WT controls. Data are shown as log 2 fold changes. ( B ) Dual-luciferase reporter analysis of Pabpn1l promoter activity following expression of TCF3, CXXC1, or both proteins. The Btg4 promoter was used as a non-target control, and TCF12 was included as a paralog control. ( C ) Co-IP analysis of the association between ectopically expressed FLAG-TCF3 and HA-CXXC1 in HeLa cells with or without DNase I treatment. ( D ) Co-IP analysis of WT and DNA-binding-deficient TCF3 and CXXC1 proteins in GV oocytes following mRNA microinjection. The TCF3 E553A, R556A mutant is defective in sequence-specific DNA binding, whereas the CXXC1 C173A mutant is defective in CpG recognition. ( E ) Representative immunofluorescence images showing the localization of WT mCherry-TCF3 or the mCherry-TCF3 E553A, R556A mutant relative to H3K4me3 in GV oocytes following mRNA microinjection. Images showing the GV region only. Scale bar, 10 μm. Data in ( B ) are presented as mean ± SD. Adjusted P values in ( A ) were obtained from DESeq2 using the Wald test with Benjamini–Hochberg correction. Statistical significance in ( B ) was determined using one-way analysis of variance (ANOVA) followed by Tukey’s HSD post hoc test for multiple comparisons. n.s. not significant; * P < 0.05; ** P < 0.01; *** P < 0.001.

    Journal: Nucleic Acids Research

    Article Title: Transcription factor 3 cooperates with CXXC finger protein 1 to regulate histone H3K4 trimethylation and developmental competence in mouse oocytes

    doi: 10.1093/nar/gkag968

    Figure Lengend Snippet: DNA-binding-dependent association between TCF3 and CXXC1 in promoting target gene transcription. ( A ) RNA-seq-derived expression changes in Pabpn1l in Tcf3 oo−/− and Cxxc1 oo−/− GV oocytes relative to their respective WT controls. Data are shown as log 2 fold changes. ( B ) Dual-luciferase reporter analysis of Pabpn1l promoter activity following expression of TCF3, CXXC1, or both proteins. The Btg4 promoter was used as a non-target control, and TCF12 was included as a paralog control. ( C ) Co-IP analysis of the association between ectopically expressed FLAG-TCF3 and HA-CXXC1 in HeLa cells with or without DNase I treatment. ( D ) Co-IP analysis of WT and DNA-binding-deficient TCF3 and CXXC1 proteins in GV oocytes following mRNA microinjection. The TCF3 E553A, R556A mutant is defective in sequence-specific DNA binding, whereas the CXXC1 C173A mutant is defective in CpG recognition. ( E ) Representative immunofluorescence images showing the localization of WT mCherry-TCF3 or the mCherry-TCF3 E553A, R556A mutant relative to H3K4me3 in GV oocytes following mRNA microinjection. Images showing the GV region only. Scale bar, 10 μm. Data in ( B ) are presented as mean ± SD. Adjusted P values in ( A ) were obtained from DESeq2 using the Wald test with Benjamini–Hochberg correction. Statistical significance in ( B ) was determined using one-way analysis of variance (ANOVA) followed by Tukey’s HSD post hoc test for multiple comparisons. n.s. not significant; * P < 0.05; ** P < 0.01; *** P < 0.001.

    Article Snippet: To minimize DNA-mediated protein associations, DNase I (HY- P72974 , MCE) was added to the lysates at a final concentration of 0.1 mg/ml, followed by incubation on ice for 30 min. Lysates were clarified by centrifugation at 12 000× g for 15 min at 4°C, and an aliquot of each supernatant was retained as the input control.

    Techniques: Binding Assay, RNA Sequencing, Derivative Assay, Expressing, Luciferase, Analysis, Activity Assay, Control, Co-Immunoprecipitation Assay, Microinjection, Mutagenesis, Sequencing, Immunofluorescence, Reporter Assay